vimarsana.com

Latest Breaking News On - Romain didier - Page 1 : vimarsana.com

Neovasc Inc : Neovasc to Sponsor Symposium on Reducer at EuroPCR

Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - May 13, 2021) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) today announced that it will sponsor a symposium

Neovasc Inc : Neovasc Announces First Neovasc Reducer Implants in France

Neovasc Inc.: Neovasc Announces First Neovasc Reducer Implants in France Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - December 15, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ( Neovasc or the Company ) announced today that it has completed the first three Neovasc Reducer ( Reducer ) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina. The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain Didier, Brest University Hospital, France. Prof. Stefan Verheye, Interventional Cardiologist at the Antwerp Cardiovascular Center in Middelheim, Belgium, provided support for the procedures. Refractory angina is a difficult burden for many French patients despite medical therapy or invasive procedures, said Prof. Gilard. I m gratified that we were able to offer the Reducer treatment for t

Neovasc Announces First Neovasc Reducer™ Implants in France

Share: VANCOUVER and MINNEAPOLIS, Dec. 15, 2020 (GLOBE NEWSWIRE) via NewMediaWire Neovasc Inc. ( Neovasc or the Company ) (NASDAQ, TSX: NVCN) announced today that it has completed the first three Neovasc Reducer™ ( Reducer ) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina. The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain Didier, Brest University Hospital, France. Prof. Stefan Verheye, Interventional Cardiologist at the Antwerp Cardiovascular Center in Middelheim, Belgium, provided support for the procedures. Refractory angina is a difficult burden for many French patients despite medical therapy or invasive procedures, said Prof. Gilard. I m gratified that we were able to offer the Reducer treatment for the first time in France.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.